Evgen Pharma
Barry Clare is the executive chairman at Evgen Pharma. Barry has previously served as a non-executive director at Walmark, chairman at Selective Beauty, and chairman and CEO at Healthcare Brands International. Barry also owned Clarat Partners LLP and was the managing director at Boots Healthcare International. Barry has dedicated their career to improving patient access to life saving cell and gene therapies.
Barry Clare is a chemist who studied at the University of Cambridge.
Some direct reports include Sally Ross - Clinical Development Officer, Richard Moulson - Chief Financial Officer.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Evgen Pharma
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is SFX-01.